1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > U.S. Kinase Inhibitors Industry 2015 Market Research Report

U.S. Kinase Inhibitors Industry 2015 Market Research Report

  • August 2015
  • -
  • QY Research Group
  • -
  • 217 pages

Summary


The U.S. Kinase Inhibitors Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Kinase Inhibitors industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Kinase Inhibitors market analysis is provided for the U.S. markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on U.S. major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Kinase Inhibitors industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 233 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

U.S. Kinase Inhibitors Industry 2015 Market Research Report
Table of Contents

Chapter One Industry Overview
1.1 Definition and Specifications of Kinase Inhibitors
1.2 Classification of Kinase Inhibitors
1.3 Applications of Kinase Inhibitors
1.4 Industry Chain Structure of Kinase Inhibitors
1.5 Industry Overview of Kinase Inhibitors
1.6 Industry Policy Analysis of Kinase Inhibitors
1.7 Industry News Analysis of Kinase Inhibitors

Chapter Two Manufacturing Cost Structure Analysis of Kinase Inhibitors
2.1 Bill of Materials (BOM) of Kinase Inhibitors
2.2 BOM Price Analysis of Kinase Inhibitors
2.3 Labor Cost Analysis of Kinase Inhibitors
2.4 Depreciation Cost Analysis of Kinase Inhibitors
2.5 Manufacturing Cost Structure Analysis of Kinase Inhibitors
2.6 Manufacturing Process Analysis of Kinase Inhibitors

Chapter Three Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of U.S. Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of U.S. Key Kinase Inhibitors Manufacturers in 2014
3.3 RandD Status and Technology Source of U.S. Kinase Inhibitors Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of U.S. Kinase Inhibitors Key Manufacturers in 2014

Chapter Four Production Analysis of Kinase Inhibitors by Regions, Technology, and Applications
4.1 U.S. Production of Kinase Inhibitors by Regions (Key Provinces) 2010-2015
4.2 U.S. Production of Kinase Inhibitors by Product Types 2010-2015
4.3 U.S. Sales of Kinase Inhibitors by Applications 2010-2015
4.4 Price Analysis of U.S. Kinase Inhibitors Key Manufacturers in 2015
4.5 U.S. Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Kinase Inhibitors 2010-2015

Chapter Five Sales and Revenue Analysis of Kinase Inhibitors by Regions
5.1 U.S. Sales of Kinase Inhibitors by Regions 2010-2015
5.2 U.S. Revenue of Kinase Inhibitors by Regions 2010-2015
5.3 U.S. Price Analysis of Kinase Inhibitors Sales by Regions 2010-2015
5.4 U.S. Price, Cost and Gross of Kinase Inhibitors 2010-2015

Chapter Six Analysis of Kinase Inhibitors Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity Production Sales Revenue of Kinase Inhibitors 2010-2015
6.2 Production Sales Market Share Analysis of Kinase Inhibitors 2014-2015
6.3 Import, Export and Consumption of Kinase Inhibitors 2010-2015
6.4 Supply, Consumption and Shortage of Kinase Inhibitors 2010-2015
6.5 Import, Export and Consumption of Kinase Inhibitors 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Kinase Inhibitors 2010-2015

Chapter Seven Analysis of Kinase Inhibitors Industry Key Manufacturers
7.1 Abbott Laboratories
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Laboratories SWOT Analysis

7.2 Amgen
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Amgen SWOT Analysis

7.3 Arqule
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Arqule SWOT Analysis

7.4 Array Biopharma
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Array Biopharma SWOT Analysis

7.5 Astrazeneca
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Astrazeneca SWOT Analysis

7.6 Aveo Pharmaceuticals
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Aveo Pharmaceuticals SWOT Analysis

7.7 Bayer
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Bayer SWOT Analysis

7.8 Bristol-Myers Squibb
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Bristol-Myers Squibb SWOT Analysis

7.9 Boehringer Ingelheim
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Boehringer Ingelheim SWOT Analysis

7.10 Cytrx Corporation
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Cytrx Corporation SWOT Analysis

7.11 Eisai
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Eisai SWOT Analysis

7.12 Eton Bioscience
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Eton Bioscience SWOT Analysis

7.13 Exelixis
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Exelixis SWOT Analysis

7.14 Glaxosmithkline
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Glaxosmithkline SWOT Analysis

7.15 Merck Serono
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Merck Serono SWOT Analysis

7.16 Novartis International
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Novartis International SWOT Analysis

7.17 Osi Pharmaceuticals
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Osi Pharmaceuticals SWOT Analysis

7.18 Pfizer
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Pfizer SWOT Analysis

7.19 Roche Group
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Roche Group SWOT Analysis

7.20 S*Bio Pte
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 S*Bio Pte SWOT Analysis

7.21 Sanofi-Aventis
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Sanofi-Aventis SWOT Analysis

7.22 Takeda Pharmaceuticals
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Takeda Pharmaceuticals SWOT Analysis

Chapter Eight Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Kinase Inhibitors Product Types
8.5 Market Share Analysis of Different Kinase Inhibitors Price Levels
8.6 Gross Margin Analysis of Different Kinase Inhibitors Applications

Chapter Nine Marketing Trader or Distributor Analysis of Kinase Inhibitors
9.1 Marketing Channels Status of Kinase Inhibitors
9.2 Traders or Distributors of Kinase Inhibitors with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Kinase Inhibitors
9.4 U.S. Import, Export and Trade Analysis of Kinase Inhibitors

Chapter Ten Development Trend of Kinase Inhibitors Industry 2015-2020
10.1 Capacity and Production Overview of Kinase Inhibitors 2015-2020
10.2 Production Market Share by Product Types of Kinase Inhibitors 2015-2020
10.3 Sales and Sales Revenue Overview of Kinase Inhibitors 2015-2020
10.4 U.S. Sales of Kinase Inhibitors by Applications 2015-2020
10.5 Import, Export and Consumption of Kinase Inhibitors 2015-2020
10.6 Cost, Price, Revenue and Gross Margin of Kinase Inhibitors 2015-2020

Chapter Eleven Industry Chain Suppliers of Kinase Inhibitors with Contact Information
11.1 Major Raw Materials Suppliers of Kinase Inhibitors with Contact Information
11.2 Manufacturing Equipment Suppliers of Kinase Inhibitors with Contact Information
11.3 Major Players of Kinase Inhibitors with Contact Information
11.4 Key Consumers of Kinase Inhibitors with Contact Information
11.5 Supply Chain Relationship Analysis of Kinase Inhibitors

Chapter Twelve New Project Investment Feasibility Analysis of Kinase Inhibitors
12.1 New Project SWOT Analysis of Kinase Inhibitors
12.2 New Project Investment Feasibility Analysis of Kinase Inhibitors

Chapter Thirteen Conclusion of the U.S. Kinase Inhibitors Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Kinase Inhibitors
Table Product Specifications of Kinase Inhibitors
Table Classification of Kinase Inhibitors
Figure U.S. Sales Market Share of Kinase Inhibitors by Product Types in 2014
Table Applications of Kinase Inhibitors
Figure U.S. Sales Market Share of Kinase Inhibitors by Applications in 2014
Figure Industry Chain Structure of Kinase Inhibitors
Table U.S. Industry Overview of Kinase Inhibitors
Table Industry Policy of Kinase Inhibitors
Table Industry News List of Kinase Inhibitors
Table Bill of Materials (BOM) of Kinase Inhibitors
Table Bill of Materials (BOM) Price of Kinase Inhibitors
Table Labor Cost of Kinase Inhibitors
Table Depreciation Cost of Kinase Inhibitors
Table Manufacturing Cost Structure Analysis of Kinase Inhibitors in 2014
Figure Manufacturing Process Analysis of Kinase Inhibitors
Table Capacity (K Person-portion) and Commercial Production Date of U.S. Kinase Inhibitors Key Manufacturers in 2014
Table Manufacturing Plants Distribution of U.S. Key Kinase Inhibitors Manufacturers in 2014
Table RandD Status and Technology Source of U.S. Kinase Inhibitors Key Manufacturers in 2014
Table Raw Materials Sources Analysis of U.S. and U.S. Kinase Inhibitors Key Manufacturers in 2014
Table U.S. Production of Kinase Inhibitors by Regions 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Kinase Inhibitors by Regions 2010-2015 (%)
Figure U.S. Production Market Share of Kinase Inhibitors by Regions in 2014
Figure U.S. Production Market Share of Kinase Inhibitors by Regions in 2015
Table U.S. Production of Kinase Inhibitors by Product Types in 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Kinase Inhibitors by Product Types in 2010-2015 (%)
Figure U.S. Production Market Share of Kinase Inhibitors by Technology in 2014
Figure U.S. Production Market Share of Kinase Inhibitors by Technology in 2015
Figure U.S. Sales of Kinase Inhibitors by Applications 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Kinase Inhibitors by Applications 2010-2015 (%)
Figure U.S. Production Market Share of Kinase Inhibitors by Applications in 2014
Figure U.S. Production Market Share of Kinase Inhibitors by Applications in 2015
Table Price Comparison of U.S. Kinase Inhibitors Key Manufacturers in 2015 (USD/Person-portion)
Table U.S. Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Kinase Inhibitors 2010-2015
Table U.S. Sales of Kinase Inhibitors by Regions 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Kinase Inhibitors by Regions 2010-2015 (%)
Figure U.S. Sales of Kinase Inhibitors by Regions in 2014 (K Person-portion)
Figure U.S. Sales of Kinase Inhibitors by Regions in 2015 (K Person-portion)
Table U.S. Revenue of Kinase Inhibitors by Regions 2010-2015 (M USD)
Table U.S. Revenue of Kinase Inhibitors by Regions 2010-2015 (%)
Figure U.S. Revenue of Kinase Inhibitors by Regions in 2014 (%)
Figure U.S. Revenue of Kinase Inhibitors by Regions in 2015 (%)
Table Sales Price of Kinase Inhibitors by Regions 2010-2015 (USD/Person-portion)
Table U.S. Price Analysis of Kinase Inhibitors 2010-2015 (USD/Person-portion)
Table U.S. Cost Analysis of Kinase Inhibitors 2010-2015 (USD/Person-portion)
Table U.S. Gross Analysis of Kinase Inhibitors 2010-2015
Table U.S. and Major Manufacturers Capacity of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. Capacity Market Share of Major Kinase Inhibitors Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Production of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. Production Market Share of Major Kinase Inhibitors Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. Sales Market Share of Major Kinase Inhibitors Manufacturers 2010-2015 (%)
Table U.S. and Major Manufacturers Sales Revenue of Kinase Inhibitors 2010-2015 (M USD)
Table U.S. Sales Revenue Market Share of Major Kinase Inhibitors Manufacturers 2010-2015 (%)
Figure U.S. Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Kinase Inhibitors 2010-2015
Figure U.S. Capacity Utilization Rate of Kinase Inhibitors 2010-2015
Figure U.S. Sales Revenue (M USD) and Growth Rate of Kinase Inhibitors 2010-2015
Figure U.S. Production Market Share of Major Kinase Inhibitors Manufacturers in 2014
Figure U.S. Production Market Share of Major Kinase Inhibitors Manufacturers in 2015
Figure U.S. Sales Market Share of Major Kinase Inhibitors Manufacturers in 2014
Figure U.S. Sales Market Share of Major Kinase Inhibitors Manufacturers in 2015
Table U.S. Import, Export and Consumption of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. and Major Manufacturers Local Sales Export Import of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. Supply, Consumption and Shortage of Kinase Inhibitors 2010-2015 (K Person-portion)
Table U.S. Import, Export and Consumption of Kinase Inhibitors 2010-2015 (K Person-portion)
Table Price of U.S. Kinase Inhibitors Major Manufacturers 2010-2015 (USD/Person-portion)
Table Gross Margin of U.S. Kinase Inhibitors Major Manufacturers 2010-2015
Table U.S. and Major Manufacturers Revenue of Kinase Inhibitors 2010-2015 (M USD)
Table U.S. Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Kinase Inhibitors 2010-2015
Table Abbott Laboratories Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Abbott Laboratories
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Abbott Laboratories 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Abbott Laboratories 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Abbott Laboratories 2010-2015
Table Abbott Laboratories Kinase Inhibitors SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Amgen
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Amgen 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Amgen 2010-2015
Table Amgen Kinase Inhibitors SWOT Analysis
Table Arqule Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Arqule
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Arqule 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Arqule 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Arqule 2010-2015
Table Arqule Kinase Inhibitors SWOT Analysis
Table Array Biopharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Array Biopharma
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Array Biopharma 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Array Biopharma 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Array Biopharma 2010-2015
Table Array Biopharma Kinase Inhibitors SWOT Analysis
Table Astrazeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Astrazeneca
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Astrazeneca 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Astrazeneca 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Astrazeneca 2010-2015
Table Astrazeneca Kinase Inhibitors SWOT Analysis
Table Aveo Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Aveo Pharmaceuticals
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Aveo Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Aveo Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Aveo Pharmaceuticals 2010-2015
Table Aveo Pharmaceuticals Kinase Inhibitors SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Bayer
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Bayer 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Bayer 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Bayer 2010-2015
Table Bayer Kinase Inhibitors SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Bristol-Myers Squibb
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Bristol-Myers Squibb 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Bristol-Myers Squibb 2010-2015
Table Bristol-Myers Squibb Kinase Inhibitors SWOT Analysis
Table Boehringer Ingelheim Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Boehringer Ingelheim
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Boehringer Ingelheim 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Boehringer Ingelheim 2010-2015
Table Boehringer Ingelheim Kinase Inhibitors SWOT Analysis
Table Cytrx Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Cytrx Corporation
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Cytrx Corporation 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Cytrx Corporation 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Cytrx Corporation 2010-2015
Table Cytrx Corporation Kinase Inhibitors SWOT Analysis
Table Eisai Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Eisai
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Eisai 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Eisai 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Eisai 2010-2015
Table Eisai Kinase Inhibitors SWOT Analysis
Table Eton Bioscience Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Eton Bioscience
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Eton Bioscience 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Eton Bioscience 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Eton Bioscience 2010-2015
Table Eton Bioscience Kinase Inhibitors SWOT Analysis
Table Exelixis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Exelixis
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Exelixis 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Exelixis 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Exelixis 2010-2015
Table Exelixis Kinase Inhibitors SWOT Analysis
Table Glaxosmithkline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Glaxosmithkline
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Glaxosmithkline 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Glaxosmithkline 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Glaxosmithkline 2010-2015
Table Glaxosmithkline Kinase Inhibitors SWOT Analysis
Table Merck Serono Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Merck Serono
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Merck Serono 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Merck Serono 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Merck Serono 2010-2015
Table Merck Serono Kinase Inhibitors SWOT Analysis
Table Novartis International Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Novartis International
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Novartis International 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Novartis International 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Novartis International 2010-2015
Table Novartis International Kinase Inhibitors SWOT Analysis
Table Osi Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Osi Pharmaceuticals
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Osi Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Osi Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Osi Pharmaceuticals 2010-2015
Table Osi Pharmaceuticals Kinase Inhibitors SWOT Analysis
Table Pfizer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Pfizer
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Pfizer 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Pfizer 2010-2015
Table Pfizer Kinase Inhibitors SWOT Analysis
Table Roche Group Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Roche Group
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Roche Group 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Roche Group 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Roche Group 2010-2015
Table Roche Group Kinase Inhibitors SWOT Analysis
Table S*Bio Pte Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of S*Bio Pte
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of S*Bio Pte 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of S*Bio Pte 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of S*Bio Pte 2010-2015
Table S*Bio Pte Kinase Inhibitors SWOT Analysis
Table Sanofi-Aventis Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Sanofi-Aventis
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Sanofi-Aventis 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Sanofi-Aventis 2010-2015
Table Sanofi-Aventis Kinase Inhibitors SWOT Analysis
Table Takeda Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Kinase Inhibitors Picture and Specifications of Takeda Pharmaceuticals
Table Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Gross (USD/Person-portion), Revenue (M USD) and Gross Margin of Takeda Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Takeda Pharmaceuticals 2010-2015
Figure Kinase Inhibitors Production (K Person-portion) and U.S. Market Share of Takeda Pharmaceuticals 2010-2015
Table Takeda Pharmaceuticals Kinase Inhibitors SWOT Analysis
Table Kinase Inhibitors Price by Regions 2010-2015
Table Kinase Inhibitors Price by Product Types 2010-2015
Table Kinase Inhibitors Price by Company 2010-2015
Table Kinase Inhibitors Gross Margin by Company 2010-2015
Table Price Comparison of Kinase Inhibitors by Regions 2010-2015 (USD/Person-portion)
Table Price of Different Kinase Inhibitors Product Types (USD/Person-portion)
Table Market Share of Different Kinase Inhibitors Price Level
Table Gross Margin of Different Kinase Inhibitors Applications
Table Marketing Channels Status of Kinase Inhibitors
Table Traders or Distributors of Kinase Inhibitors with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Kinase Inhibitors (USD/Person-portion)
Table U.S. Import, Export, and Trade of Kinase Inhibitors (K Person-portion)
Figure U.S. Capacity (K Person-portion), Production (K Person-portion) and Growth Rate of Kinase Inhibitors 2015-2020
Figure U.S. Capacity Utilization Rate of Kinase Inhibitors 2015-2020
Table U.S. Kinase Inhibitors Production by Product Types 2010-2015 (K Person-portion)
Table U.S. Kinase Inhibitors Production Market Share by Product Types 2010-2015 (%)
Figure U.S. Production Market Share of Kinase Inhibitors by Technology in 2020
Figure U.S. Sales (K Person-portion) and Growth Rate of Kinase Inhibitors 2015-2020
Figure U.S. Sales Revenue (Million USD) and Growth Rate of Kinase Inhibitors 2015-2020
Figure U.S. Sales of Kinase Inhibitors by Applications 2015-2020 (K Person-portion)
Table U.S. Production Market Share of Kinase Inhibitors by Applications 2015-2020 (%)
Figure U.S. Production Market Share of Kinase Inhibitors by Applications in 2020
Table U.S. Production, Import, Export and Consumption of Kinase Inhibitors 2015-2020 (K Person-portion)
Table U.S. Production (K Person-portion), Price (USD/Person-portion), Cost (USD/Person-portion), Revenue (M USD) and Gross Margin of Kinase Inhibitors 2015-2020
Table Major Raw Materials Suppliers of Kinase Inhibitors with Contact Information
Table Manufacturing Equipment Suppliers of Kinase Inhibitors with Contact Information
Table Major Players of Kinase Inhibitors with Contact Information
Table Key Consumers of Kinase Inhibitors with Contact Information
Table Supply Chain Relationship Analysis of Kinase Inhibitors
Table New Project SWOT Analysis of Kinase Inhibitors
Table New Project Investment Feasibility Analysis of Kinase Inhibitors
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Colorectal Cancer KOL Insight 2016

Colorectal Cancer KOL Insight 2016

  • $ 8085
  • Industry report
  • October 2016
  • by Firstword Pharma

KOLs embrace novel MoAs as low survival rates drive search for new treatments Faced with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). ...

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

Sunitinib Malate Market: By Disease (Pancreatic Neuroendocrine Tumors & Kidney Cancer) & By Region (Europe, North America, Asia-Pacific & Rest of the World (RoW))-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Sunitinib, developed and marketed as Sutent by Pfizer Inc and previously known as SU11248, is a small-molecule medicine which has to be administered orally and has been proven to be effective in blocking ...

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies

  • $ 4995
  • Industry report
  • September 2016
  • by GBI Research

Gastric Cancer Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Increasing Prevalence and Launch of Targeted Therapies Summary Gastric cancer is characterized by the formation of malignant ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.